The analysis of the cell cycle profile of treated cells was examined by the evaluation of a marker of mitosis, Histone H3-pSer10, and a marker of the G1/S transition, Cdk2-pTyr15, to explore the mechanism underlying the inhibition of melanoma cell viability. The gene discussed is CDK2; the disease is melanoma.